Displasia broncopolmonare

Polmoni di ferro

Pascolo P, Cotić I, Krivec U

2025/7 — pag. 188-189 — DOI

An extremely premature infant (24 weeks’ gestation, birth weight 380 g) with congenital heart disease and severe bronchopulmonary dysplasia is hospitalized for worsening respiratory function, hypoxia and rising eosinophilia in the absence of infectio...

Dalla Terapia Intensiva Neonatale alla Pediatria di famiglia

Aversa S, Risso FM.

2023/2 — pag. 103-109 — DOI

Discharge planning of preterm infants and transition from the neonatologist to the primary care paediatrician are key components of family-centred Neonatal Intensive Care Unit care. Growth support and monitoring, feeding choices, management of gastro...

La Neonatologia… caso per caso

D’Agostin M, Catania MA, Giambrone C, Corsello G.

2023/1 — pag. 38-44 — DOI

Neonatal hypotonia, bronchopulmonary dysplasia, necrotizing enterocolitis and persistent hypoglycemia are some of the main topics in neonatology. This work aims to summarize these four neonatal conditions through illustrative clinical cases. The firs...

La profilassi dell’infezione da virus respiratorio sinciziale: dal palivizumab al nirsevimab

Servadio M, Belleudi V, Marchetti F, Addis A.

2022/10 — pag. 632-639 — DOI

The Respiratory Syncytial Virus (RSV) is considered the leading cause of lower respiratory tract infections (LRTI) in children aged < 2 years. In high-risk children, including preterm infants, or in children with bronchopulmonary dysplasia (BPD) and ...

Il neonato a colori: le sfumature di grigio

G. Corsello, M. Schierz

2019/7 — pag. 455-456

Il neonato a colori: nero a metà

G. Corsello, M. Schierz

2019/2 — pag. 115-116

Una broncodisplasia complicata

P. Pascolo, G. Facchina

2015/8

I corticosteroidi nelle malattie respiratorie: certezze e dubbi 60 anni dopo (Seconda parte)

F.M. de Benedictis, F. Franceschini, R. Budassi, A. Capolongo, C. Gobbi, A. Guerrieri, C. Migliori, A. Nobilini, C. Pasqualini

2012/10 — pag. 652-659

Corticosteroids are anti-inflammatory drugs which are used in many pulmonary conditions, either systemically or by inhalation. Corticosteroids have a proven beneficial role in asthma, croup, allergic bronchopulmonary aspergillosis and subglottic he...

Costo della nascita pretermine in Inghilterra e Galles

G. Bartolozzi

2009/5

Malattie da altitudine

G. Bartolozzi

2008/4 — pag. 239-243

Children less than one year old can be taken to altitudes up to 2,500 meters, like adults with minor or medium severity heart and lung conditions. Higher altitudes can cause severe reactions, including acute mountain sickness and pulmonary and cere...

Il surfattante nella difficoltà respiratoria del pretermine e del nato a termine

G. Bartolozzi

2008/4

La displasia broncopolmonare e la sua gestione domiciliare

Luciano Anfossi, Stefania Fassio, Anna Rita Berghelli

2007/6 — pag. 375-380

Bronchopulmonary dysplasia (BPD) is considered one of the primary causes of chronic lung disease among infants. Pathogenesis is complex, being primarily influenced by prematurity, infection, supplementary oxygen and mechanical ventilation. Prevention...

Effetto dell'ossido nitrico inalato nei nati pretermine con grave insufficienza respiratoria

G. Bartolozzi

2005/9

Bronco-pneumopatia da incoordinazione della deglutizione

I. Berti, S. Martelossi, A. Ventura

2001/9

Il trattamento del neonato con desametasone altera lo sviluppo della corteccia cerebrale

G. Bartolozzi

2001/4

Il virus respiratorio sinciziale

G. Bartolozzi

1999/10

Palivizumab: un anticorpo monoclonale umanizzato contro il virus respiratorio sinciziale

L. De Seta, G. Orso

1999/8 — pag. 491-494

Respiratory Syncytial Virus (RSV) is the main cause of respiratory infections in the first years of life. Preterm infants and those affected by broncopulmonary dysplasia (BPD) represent the categories at highest risk of severe RSV infections. Paliv...